-
Tata India Pharma & Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 22/10/24 )
NAV
₹30.31
Last change
₹-0.51 -0.02%
Fund Size (AUM)
1208.25 Cr
Performance
27.7% (5Y)
Fund Details
Tata India Pharma & Healthcare Fund Regular Growth
as of 22/10/24
AUM
1208.25 Cr
Expense Ratio
2.13 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K016A9
Fund Manager
Meeta Shetty
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular Growth | 51.6% | 20.71% | 27.7% |
| Nifty Pharma TR INR | 55.23% | 19.24% | 28.77% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
12.83% |
Aurobindo Pharma Ltd |
8.96% |
Lupin Ltd |
7.44% |
Dr Reddy's Laboratories Ltd |
6.87% |
Cipla Ltd |
6.71% |
Divi's Laboratories Ltd |
4.73% |
Fortis Healthcare Ltd |
4.35% |
Zydus Lifesciences Ltd |
4.17% |
Alkem Laboratories Ltd |
3.77% |
Apollo Hospitals Enterprise Ltd |
3.51% |
Sector Allocation
Healthcare |
97.88% |
Basic Materials |
2.12% |
Asset Allocation
-
94%
Equity
-
6%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
31.28% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
30.49% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
30.49% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
28.4% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
32.23% (5Y)
-
-
Nippon India Pharma IDCW-P
Equity healthcare-
Returns
-
32.13% (5Y)
-
